Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Changes in Healthcare Resource Use and Costs in Commercially Insured Insomnia Patients Initiating Suvorexant ; volume:38 ; number:10 ; day:31 ; month:8 ; year:2021 ; pages:5221-5237 ; date:10.2021
Advances in therapy ; 38, Heft 10 (31.8.2021), 5221-5237, 10.2021
- Creator
-
Kale, Hrishikesh P.
Qureshi, Zaina P.
Shah, Ruchit
Khandker, Rezaul
Botteman, Marc
Meng, Weilin
Benca, Ruth
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-021-01891-8
- URN
-
urn:nbn:de:101:1-2022021918282099554254
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:29 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kale, Hrishikesh P.
- Qureshi, Zaina P.
- Shah, Ruchit
- Khandker, Rezaul
- Botteman, Marc
- Meng, Weilin
- Benca, Ruth
- SpringerLink (Online service)
Other Objects (12)
Trends in heart failure costs for commercially insured patients in the United States (2006–2021)
Care Among Migraine Patients in a Commercially Insured Population
Financial outcomes after pediatric critical illness among commercially insured families
Healthcare use in commercially insured youth with mental health disorders
Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years
Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Area-level deprivation and preterm birth: results from a national, commercially-insured population
Systemic overuse of health care in a commercially insured US population, 2010–2015
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa
Trends in heart failure costs for commercially insured patients in the United States (2006–2021)
Care Among Migraine Patients in a Commercially Insured Population
Financial outcomes after pediatric critical illness among commercially insured families
Healthcare use in commercially insured youth with mental health disorders
Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years
Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Area-level deprivation and preterm birth: results from a national, commercially-insured population
Systemic overuse of health care in a commercially insured US population, 2010–2015
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States
Assessing the geographical distribution of comorbidity among commercially insured individuals in South Africa
Trends in heart failure costs for commercially insured patients in the United States (2006–2021)
Care Among Migraine Patients in a Commercially Insured Population
Financial outcomes after pediatric critical illness among commercially insured families
Healthcare use in commercially insured youth with mental health disorders
Community-Acquired Pneumonia Episode Costs by Age and Risk in Commercially Insured US Adults Aged ≥50 Years
Chemotherapy-induced febrile neutropenia (FN): healthcare resource utilization (HCRU) and costs in commercially insured patients in the US
Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults
Healthcare resource utilization and costs before and after long-acting injectable antipsychotic initiation in commercially insured young adults with schizophrenia
Area-level deprivation and preterm birth: results from a national, commercially-insured population
Systemic overuse of health care in a commercially insured US population, 2010–2015
Epidemiology of rhegmatogenous retinal detachment in commercially insured myopes in the United States